SeaStar Medical Holding Corporation (ICU)
NASDAQ: ICU · Real-Time Price · USD
2.299
-0.081 (-3.40%)
Dec 3, 2024, 11:54 AM EST - Market open
SeaStar Medical Holding Employees
SeaStar Medical Holding had 12 employees as of December 31, 2023. The number of employees increased by 3 or 33.33% compared to the previous year.
Employees
12
Change (1Y)
3
Growth (1Y)
33.33%
Revenue / Employee
$5,667
Profits / Employee
-$2,489,000
Market Cap
10.26M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 12 | 3 | 33.33% |
Dec 31, 2022 | 9 | 6 | 200.00% |
Dec 31, 2021 | 3 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Evogene | 142 |
PAVmed | 107 |
ImmunoPrecise Antibodies | 101 |
IM Cannabis | 95 |
MSP Recovery | 88 |
Turnstone Biologics | 80 |
RedHill Biopharma | 53 |
QT Imaging Holdings | 14 |
ICU News
- 7 days ago - SeaStar Medical to Present at Noble Capital Markets' NobleCon20 on December 4, 2024 - GlobeNewsWire
- 11 days ago - Leading Independent Proxy Advisory Firms ISS and Glass Lewis Support SeaStar Medical's Proposals to Ratify the Issuance of Shares and to Reduce the Number of Authorized Shares - GlobeNewsWire
- 18 days ago - SeaStar Medical Reaches Milestone of 100th QUELIMMUNE Commercial Device as Shipments Begin to its Third Hospital Customer - GlobeNewsWire
- 19 days ago - SeaStar Medical Reports Third Quarter 2024 Financial Results and Provides a Business Update - GlobeNewsWire
- 4 weeks ago - Record Monthly Enrollment Achieved in SeaStar Medical's Pivotal Adult AKI Trial - GlobeNewsWire
- 4 weeks ago - SeaStar Medical Adds Second Hospital Customer for QUELIMMUNE - GlobeNewsWire
- 5 weeks ago - Economic Analysis Supporting Significant Hospitalization Cost Reduction with SeaStar Medical's QUELIMMUNE Pediatric Therapeutic Device Presented at ASN Kidney Week 2024 - Update - GlobeNewsWire
- 5 weeks ago - Economic Analysis Supporting Significant Hospitalization Cost Reduction with SeaStar Medical's QUELIMMUNE Pediatric Therapeutic Device Presented at ASN Kidney Week 2024 - GlobeNewsWire